The Effect of nurses telephone follow-up on the self-efficacy of dietary behavior and physical activity in patients with nonalcoholic fatty liver disease

The Effect of nurses telephone follow-up (Telenursing) on the self-efficacy of dietary behavior and physical activity in patients with nonalcoholic fatty liver disease referred to subspeciality gastrointestinal Clinics of Shiraz

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015040411691N5

Enrollment

Registered

2015-06-21

Start date

2013-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic Fatty Liver. Other specified inflammatory liver diseases

Interventions

Intervention 1: Intervention group : Before and after intervention, Questionnaires related to the self-efficacy of dietary behavior and physical activity were completed by study participants .The pat

Lifestyle

Intervention group : Before and after intervention, Questionnaires related to the self-efficacy of dietary behavior and physical activity were completed by study participants .The patients received

Control group : Before and after intervention, Questionnaires related to the self-efficacy of dietary behavior and physical activity were completed by study participants .The patients received dieta

Eligibility

Sex/Gender

All

Age

19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:19 years and over; the incidence of overweight or obesity; capability to perform moderate physical activity confirmed by medical professionals; accessibility to a telephone at home; lack of any speech and hearing problems. Exclusion criteria: history of chronic liver disease such as viral or drug hepatitis; confirmed diagnosis of Wilson diseases; primary hemochromatosis; hyperthyroidism or hypothyroidism; bile duct cancer; diabetes mellitus; obesity due to excessive use of corticosteroid; Cushing's syndrome; Addison syndrome; chronic infections such as tuberculosis; use of hepatotoxic drugs within the past 6 months; incidence of gall stones in the gallbladder having exposure to petrochemicals; alcohol consumption; drug abuse;genetic diseases related to lipid disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Dietary behavior self efficacy. Timepoint: Before and three months after intervention. Method of measurement: dietary behavior self-efficacy Questionnaire ( sherer &madox).;Physical activity self-efficacy. Timepoint: Before and three months after intervention. Method of measurement: Exercise Self-Efficacy Questionnaire( pender).	—

Secondary

Measure	Time frame
Weight average. Timepoint: Before and three months after intervention. Method of measurement: scale.;Lipid average. Timepoint: Before and three months after intervention. Method of measurement: Blood test.;Liver Enzymes Average. Timepoint: Before and three months after intervention. Method of measurement: Blood test.;Liver size average. Timepoint: Before and three months after intervention. Method of measurement: Ultrasound.	—

Measure

Time frame

Weight average. Timepoint: Before and three months after intervention. Method of measurement: scale.;Lipid average. Timepoint: Before and three months after intervention. Method of measurement: Blood test.;Liver Enzymes Average. Timepoint: Before and three months after intervention. Method of measurement: Blood test.;Liver size average. Timepoint: Before and three months after intervention. Method of measurement: Ultrasound.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Ghodsbin

Shiraz University of Medical Sciences

vcrdep@sums.ac.irghodsbin@sums.ac.ir+98 71 3230 5410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026